Contracts › HHSO100201700012C
HHSO100201700012C: Igf::Ot::Igf
Awarded to Merck Sharp & Dohme Llc by Office of Assistant Secretary for Preparedness and Response.
$236.3Mobligated
$291.4Mpotential value
27 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HHSO100201700012C |
|---|---|
| Awardee | Merck Sharp & Dohme Llc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NJ |
| Offers received | 2 |
| Period of performance | 28 September 2017 to 27 September 2027 |
| Potential end | 27 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record